Home›Companies›Artificial Intelligence›Aevius AI

Aevius Labs, Inc.

Develops a patient-record AI model for health systems, payers and life sciences organizations.

Updated Nov 10, 2026·Latest SEC filing Jul 2, 2026·Suggest an edit

About Aevius AI

Aevius AI is a private company based in Boston, Massachusetts, incorporated in 2026 in Delaware. It has reported $2,000,000 raised in one offering on Form D since March 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 10, 2026Mar 11, 2026amended Jul 2, 2026$2,000,000fully sold13$153KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aevius AI's Form D filed Jul 2, 2026.

ML
Ming Yang Lu
Executive officer and director

Sources

  1. SECAevius Labs, Inc. Form D, filed Mar 11, 2026
  2. SECAevius Labs, Inc. filing history